Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 1/2019

Content (11 Articles)

Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer

Maxime Chénard-Poirier , Elizabeth C. Smyth

Recent Developments in Male Contraception

  • Leading Article

Arthi Thirumalai, Stephanie T. Page

Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives

  • Open Access
  • Review Article

Aura D. Herrera-Martínez, Johannes Hofland, Leo J. Hofland, Tessa Brabander, Ferry A. L. M. Eskens, María A. Gálvez Moreno, Raúl M. Luque, Justo P. Castaño, Wouter W. de Herder, Richard A. Feelders

Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice

Carla Greenbaum, Dana VanBuecken, Sandra Lord

Targeting Angiogenesis in Colorectal Carcinoma

Anthony Lopez, Kazuto Harada, Maria Vasilakopoulou, Namita Shanbhag, Jaffer A. Ajani

Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease

  • Review Article

Samarth Siddharth Patel, Mohammad Shadab Siddiqui

Revefenacin: First Global Approval

  • Open Access
  • AdisInsight Report

Young-A Heo

Lorlatinib: First Global Approval

  • NSCLC
  • AdisInsight Report

Yahiya Y. Syed

Emapalumab: First Global Approval

Zaina T. Al-Salama

Correction to: Moxetumomab Pasudotox: First Global Approval

  • Open Access
  • Correction

Sohita Dhillon

Correction to: Ivosidenib: First Global Approval

  • Open Access
  • Correction

Sohita Dhillon

Dec 18
Issue: 18/2018
Feb 19
Issue: Special Issue 1/2019
l-Ornithine l-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images